Roni Mamluk - Net Worth and Insider Trading
Roni Mamluk Net Worth
The estimated net worth of Roni Mamluk is at least $3,924 dollars as of 2024-12-28. Roni Mamluk is the President & CEO of Ayala Pharmaceuticals Inc and owns about 145,345 shares of Ayala Pharmaceuticals Inc (ADXS) stock worth over $3,924. Roni Mamluk is also the Director of Chiasma Inc and owns about 0 shares of Chiasma Inc (CHMA) stock worth over $0. Details can be seen in Roni Mamluk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Roni Mamluk has not made any transactions after 2021-02-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Roni Mamluk
Roni Mamluk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roni Mamluk owns 2 companies in total, including Chiasma Inc (CHMA) , and Ayala Pharmaceuticals Inc (ADXS) .
Click here to see the complete history of Roni Mamluk’s form 4 insider trades.
Insider Ownership Summary of Roni Mamluk
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CHMA | Chiasma Inc | 2021-02-09 | director |
| ADXS | Ayala Pharmaceuticals Inc | 2021-02-24 | director & CEO |
Roni Mamluk Latest Holdings Summary
Roni Mamluk currently owns a total of 2 stocks. Among these stocks, Roni Mamluk owns 145,345 shares of Ayala Pharmaceuticals Inc (ADXS) as of February 24, 2021, with a value of $3,924 and a weighting of 100%. Roni Mamluk also owns 0 shares of Chiasma Inc (CHMA) as of February 9, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Roni Mamluk
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADXS | Ayala Pharmaceuticals Inc | 2021-02-24 | 145,345 | 0.03 | 3,924 |
| CHMA | Chiasma Inc | 2021-02-09 | 0 | 3.76 | 0 |
Holding Weightings of Roni Mamluk
Roni Mamluk Form 4 Trading Tracker
According to the SEC Form 4 filings, Roni Mamluk has made a total of 2 transactions in Ayala Pharmaceuticals Inc (ADXS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Ayala Pharmaceuticals Inc is the sale of 33,126 shares on February 24, 2021, which brought Roni Mamluk around $617,137.
According to the SEC Form 4 filings, Roni Mamluk has made a total of 2 transactions in Chiasma Inc (CHMA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Chiasma Inc is the sale of 27,981 shares on February 9, 2021, which brought Roni Mamluk around $139,905.
Insider Trading History of Roni Mamluk
- 1
Roni Mamluk Trading Performance
Roni Mamluk Ownership Network
Roni Mamluk Owned Company Details
What does Chiasma Inc do?
Who are the key executives at Chiasma Inc?
Roni Mamluk is the director of Chiasma Inc. Other key executives at Chiasma Inc include director & Chief Executive Officer Raj Kannan , EVP & Chief Commerical Officer Anand Varadan , and President Mark J. Fitzpatrick .
Chiasma Inc (CHMA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Chiasma Inc (CHMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chiasma Inc (CHMA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Chiasma Inc (CHMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chiasma Inc Insider Transactions
Roni Mamluk Mailing Address
Above is the net worth, insider trading, and ownership report for Roni Mamluk. You might contact Roni Mamluk via mailing address: Chiasma, Inc., 60wells Avenue, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
